Steelhead Partners »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Steelhead Partners

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Steelhead Partners from 13F filings

Historical chart of Steelhead Partners investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Steelhead Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Steelhead Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $51B 45M 1137.97
2024-06-30 $71B 55M 1290.27
2024-03-31 $38B 32M 1170.37
2023-12-31 $16B 16M 1013.97

More positions owned by Steelhead Partners

Sealtd 0 1/4 09/15/26 Note 0.250% 9/1 (Principal)
Spot 0 03/15/26 Note 3/1 (Principal)
Net 0 08/15/26 Note 8/1 (Principal)
Itri 0 03/15/26 Note 3/1 (Principal)
Luv 1 1/4 05/01/25 Note 1.250% 5/0 (Principal)
DXCM 0 1/4 11/15/25 Note 0.250%11/1 (Principal)
Uber 0 12/15/25 Note 12/1 (Principal)
CFLT 0 01/15/27 Note 1/1 (Principal)
Lite 0 1/2 12/15/26 Note 0.500%12/1 (Principal)
Idcc 3 1/2 06/01/27 Note 3.500% 6/0 (Principal)
Ions 1.75 06/15/28 Note 1.750% 6/1 (Principal)
SRPT 1 1/4 09/15/27 Note 1.250% 9/1 (Principal)
FVRR 0 11/01/25 Note 11/0 (Principal)
GBX 2 7/8 04/15/28 Note 2.875% 4/1 (Principal)
Etsy 0 1/4 06/15/28 Note 0.250% 6/1 (Principal)

View all positions for Steelhead Partners

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1